168 related articles for article (PubMed ID: 18285676)
21. A review of infliximab use in ulcerative colitis.
Wilhelm SM; McKenney KA; Rivait KN; Kale-Pradhan PB
Clin Ther; 2008 Feb; 30(2):223-30. PubMed ID: 18343261
[TBL] [Abstract][Full Text] [Related]
22. Infliximab and pediatric stricturing Crohn's disease: a possible alternative to surgery? Experience of seven cases.
Gasparetto M; Corradin S; Vallortigara F; Cananzi M; Guariso G
Acta Gastroenterol Belg; 2012 Mar; 75(1):58-60. PubMed ID: 22567750
[TBL] [Abstract][Full Text] [Related]
23. Clinical factors predictive of Crohn's disease complications and surgery.
Cerqueira RM; Lago PM
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):129-34. PubMed ID: 23104203
[TBL] [Abstract][Full Text] [Related]
24. The impact of infliximab infusion reactions on long-term outcomes in patients with Crohn's disease.
Moss AC; Fernandez-Becker N; Jo Kim K; Cury D; Cheifetz AS
Aliment Pharmacol Ther; 2008 Jul; 28(2):221-7. PubMed ID: 18485127
[TBL] [Abstract][Full Text] [Related]
25. Heterogeneity in endoscopic treatment of Crohn's disease-associated strictures: An international inflammatory bowel disease specialist survey.
Bettenworth D; Lopez R; Hindryckx P; Levesque BG; Rieder F
J Gastroenterol; 2016 Oct; 51(10):939-48. PubMed ID: 26831355
[TBL] [Abstract][Full Text] [Related]
26. Metastatic vulval Crohn's disease and infliximab: a case report.
Tritton SM; Whyte L; Fischer G
J Reprod Med; 2009 Jan; 54(1):41-4. PubMed ID: 19263879
[TBL] [Abstract][Full Text] [Related]
27. Therapeutic efficacy of infliximab on patients with short duration of Crohn's disease: a Japanese multicenter survey.
Matsumoto T; Iida M; Motoya S; Haruma K; Suzuki Y; Kobayashi K; Ito H; Miyata M; Kusunoki M; Chiba T; Yamamoto S; Hibi T
Dis Colon Rectum; 2008 Jun; 51(6):916-23. PubMed ID: 18322754
[TBL] [Abstract][Full Text] [Related]
28. [Perianal fistulas in Crohn's disease--biologicals and surgery: is it worthwhile?].
Bode M; Eder S; Schürmann G
Z Gastroenterol; 2008 Dec; 46(12):1376-83. PubMed ID: 19053007
[TBL] [Abstract][Full Text] [Related]
29. Induction of pustular lesions during infliximab therapy for Crohn's disease.
Pérez-Pérez L; Caeiro JL; Fabeiro JM; Allegue F; Zulaica A
Acta Derm Venereol; 2008; 88(3):292-3. PubMed ID: 18480940
[No Abstract] [Full Text] [Related]
30. Factors associated with the development of intestinal strictures or obstructions in patients with Crohn's disease.
Sorrentino D
Am J Gastroenterol; 2006 Dec; 101(12):2892-3. PubMed ID: 17227539
[No Abstract] [Full Text] [Related]
31. Infliximab treatment for anal fistula in patients with Crohn's disease.
Higashi D; Futami K; Egawa Y; Hirano K; Tomiyasu T; Ishibashi Y; Simomura T; Nii K; Kuroki H; Maekawa T; Ono Y; Matsui T
Anticancer Res; 2009 Mar; 29(3):927-33. PubMed ID: 19414329
[TBL] [Abstract][Full Text] [Related]
32. Onset of flexural psoriasis during infliximab treatment for Crohn's disease.
Peramiquel L; Puig L; Dalmau J; Ricart E; Roe E; Alomar A
Clin Exp Dermatol; 2005 Nov; 30(6):713-4. PubMed ID: 16197398
[No Abstract] [Full Text] [Related]
33. How early to take arms against a sea of troubles? The case for aggressive early therapy in Crohn's disease to prevent fibrotic intestinal strictures.
Govani SM; Stidham RW; Higgins PD
J Crohns Colitis; 2013 Dec; 7(11):923-7. PubMed ID: 23880128
[TBL] [Abstract][Full Text] [Related]
34. [Infliximab-induced pustular psoriasis in a patient with Crohn's disease].
Monteagudo Sánchez B; Cabanillas M; Ortiz-Marin S; Gallego-Ojea JC
Gastroenterol Hepatol; 2009 Mar; 32(3):175-6. PubMed ID: 19233516
[No Abstract] [Full Text] [Related]
35. Proteomics for prediction and characterization of response to infliximab in Crohn's disease: a pilot study.
Meuwis MA; Fillet M; Lutteri L; Marée R; Geurts P; de Seny D; Malaise M; Chapelle JP; Wehenkel L; Belaiche J; Merville MP; Louis E
Clin Biochem; 2008 Aug; 41(12):960-7. PubMed ID: 18489908
[TBL] [Abstract][Full Text] [Related]
36. Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
Miheller P; Muzes G; Lakatos G; Mihály E; Tulassay Z
J Emerg Med; 2007 Feb; 32(2):209-10; author reply 210. PubMed ID: 17307639
[No Abstract] [Full Text] [Related]
37. Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
Peyrin-Biroulet L; Bressenot A; Chone L; Denjean P; Boissel P; Bigard MA; Bronowicki JP
Am J Gastroenterol; 2006 Nov; 101(11):2664-5. PubMed ID: 17090288
[No Abstract] [Full Text] [Related]
38. Transient type III atrioventricular block after infliximab infusion in a fistulizing perianal Crohn's disease patient.
Sofos S; Savoye G; Ramirez S; Bauer F; Lerebours E
Am J Gastroenterol; 2007 Jan; 102(1):217-9. PubMed ID: 17278277
[No Abstract] [Full Text] [Related]
39. Relationship of the number of Crohn's strictures and strictureplasties to postoperative recurrence.
Greenstein AJ; Zhang LP; Miller AT; Yung E; Branco BC; Sachar DB; Greenstein AJ
J Am Coll Surg; 2009 Jun; 208(6):1065-70. PubMed ID: 19476893
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
Bharadwaj S; Fleshner P; Shen B
Inflamm Bowel Dis; 2015 Sep; 21(9):2194-213. PubMed ID: 25985249
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
